New Genentech method patent-->Combined use of EGFR inhibitors + Trail-R agonists. I would like to see Imclone move forward with clinical trials that use a combination of targeted therapies (Erbitux+ other biologically targeted drugs).
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.